s6y
Company name or ticker
Search
20/20 Biolabs, Inc.
SCHEDULE 13D
Filing
Filed
Tuesday, March 10, 2026
Accession number
0001213900-26-025764
Documents
primary_doc.xml
SCHEDULE 13D
On sec.gov
Filing index
All files
Complete submission text
SGML header